| 5-ASA and derivatives |
| Balsalazide | 750 mg three times daily | $28 |
| Mesalamine, MMX delayed release | 1.2 g twice daily | $95 |
| Mesalamine enema | 4 g daily | $165 |
| Mesalamine suppository | 1 g daily | $125 |
| Olsalazine (Dipentum) | 500 mg twice daily | $1,590 |
| Sulfasalazine (Azulfidine) | 500 mg four times daily | $21 |
| Corticosteroids |
| Hydrocortisone enema | 100 mg daily | $159 |
| Budesonide, extended release (Uceris) | 9 mg daily for up to eight weeks | $402 |
| Interleukin-12 and interleukin-23 inhibitor |
| Ustekinumab (Stelara) | 260- to 520-mg induction dose (weight based), then 90 mg every eight weeks | $22,650 per 90-mg syringe |
| Janus kinase inhibitor |
| Tofacitinib (Xeljanz) | 10 mg twice daily for eight weeks, then 5 to 10 mg twice daily | $4,860 for 10 mg twice daily |
| Selective adhesion molecule inhibitor |
| Vedolizumab (Entyvio) | 300 mg at weeks 0, 2, and 6, then 300 mg every eight weeks | $7,169 per dose |
| Tumor necrosis factor–alpha inhibitors |
| Adalimumab (Humira) | 160 mg at week 0, 80 mg at week 2, then 40 mg every other week | $5,809 per month (two 40-mg syringes) |
| Golimumab (Simponi) | 200 mg at week 0, 100 mg at week 2, then 100 mg every four weeks | $5,968 per 100-mg dose |
| Infliximab (Remicade) | 5 mg per kg at weeks 0, 2, and 6, then every eight weeks | $1,895 per 100-mg vial |
